IndraLab

Statements


P5091 inhibits DDX53. 1 / 1
| 1

reach
"As shown in Figure 1A, P5091 inhibited the growth of CT26 xenografts in a dose-dependent manner, as evidenced by tumor volume and the fact that a high-dose treatment of P5091 had the same effect as anti-PD-1 treatment."